Parkinson's disease is rarely a primary cause of death

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7032.703 (Published 16 March 1996) Cite this as: BMJ 1996;312:703
  1. Mark T Silva,
  2. Paul M Watts,
  3. Peter Jenner
  1. MRC research fellow MRC research fellow Director Neurodegenerative Diseases Research Centre, Pharmacology Group, King's College London, London SW3 6LX

    EDITOR,—As many patients with Parkinson's disease in Britain currently receive selegiline, any conclusions drawn from the Parkinson's Disease Research Group's study will have important implications.1 The decision to close arm 2 of the trial (levodopa plus selegiline) may precipitate a change in prescribing practice. While the research group does not draw any firm conclusions about the causal relation between treatment with selegiline and excess mortality, many readers will nevertheless infer such a connection.

    Several points are relevant. Most of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription